Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

Tietokoneavusteinen itsekoulutus executive-toimintojen parantamiseksi (COMPEX)

tiistai 29. syyskuuta 2026 päivittänyt: Hanne Christensen, Bispebjerg Hospital

Computer-Assisted Self-Training to Improve Executive Function Versus Unspecific Training in Patients After Stroke, Cardiac Arrest or in Parkinson's Disease: A Randomized Controlled Trial

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to generally cognitively stimulating activities on a computer

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

This project explores the effects of specialized computer-based cognitive rehabilitation (CBCR) targeting executive functions in three groups of patients: Stroke, Cardiac Arrest and Parkinson's Disease. The effect of specialized CBCR is compared to completing generally cognitively stimulating activities on a computer. A total of 307 patients is expected to be enrolled. All patients will complete a neuropsychological test battery assessing executive functions at inclusion, directly after the eight-week training period and at follow-up three months after the end of the intervention period. Furthermore, all patients will answer questionnaires concerning quality of life and ADL-measures at baseline, after the intervention and at follow-up. All patients will train for a period of 8 weeks, 5 times a week for 60 minutes regardless of their group allocation.

Opintotyyppi

Interventio

Ilmoittautuminen (Arvioitu)

307

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

      • Copenhagen, Tanska
        • Rigshospitalet
      • Copenhagen, Tanska
        • Bispebjerg Hospital

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

18 vuotta - 100 vuotta (Aikuinen, Vanhempi Aikuinen)

Hyväksyy terveitä vapaaehtoisia

Ei

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • A diagnose of stroke, cardiac arrest or Parkinson's disease.
  • Aged 18 years or older.
  • Impaired working memory measured with CABPad working memory test, cut off for inclusion: 5 symbols or less backwards
  • Computer and internet access at home.
  • Providing informed consent.

Inclusion criteria specific for stroke

  • Inclusion within 6 months post-stroke
  • Stroke confirmed by clinical findings and imaging, both AIS and ICH is allowed.
  • Initial stroke severity >/= NIHSS 3.

Inclusion criteria specific for cardiac arrest

• Inclusion within 6 months post ictus.

Inclusion criteria specific for Parkinson's disease

  • Clinical diagnosis of PD.
  • Anti-parkinsonian medical treatment (dopaminergic or other).

Exclusion Criteria:

  • Informed consent not provided
  • Other neurological or psychiatric disease which is expected to influence the patient's ability to participate in the trial according to the investigator
  • Not able to participate according to investigator

Exclusion criteria specific for stroke

  • Patients with massive anosognosia for executive dysfunction or patients with no subjective feeling of executive dysfunction (Patient sustains total denial of executive symptoms over time)
  • Patients with severe aphasia, in which it is unclear whether the patient's performance on a neuropsychological test-battery is due to aphasia and not executive dysfunction.

Exclusion criteria specific for cardiac arrest • None

Exclusion criteria specific for PD

• Diagnosis of PD Dementia according to the MDS PD Dementia criteria

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Hoito
  • Jako: Satunnaistettu
  • Inventiomalli: Rinnakkaistehtävä
  • Naamiointi: Yksittäinen

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Kokeellinen: Specific computer-based cognitive rehabilitation

154 patients will be allocated to specific computer-based cognitive rehabilitation. This group will train with 10 exercises from the cognitive rehabilitation software 'Scientific Brain training PRO'. These 10 exercises are designed to train various executive functions.

CBCR are software-programmes for computers which are clinically developed for rehabilitation of various cognitive functions.

Active Comparator: General computer-based cognitive stimulation

154 patients will be allocated to general computer-based cognitive stimulation. This group will train with 10 generally mentally stimulating games on a website specifically designed for this trial. These 10 games are chosen because they are believed to have a low load on executive functions but stimulate over-all concentration and visuoperceptual abilities.

For this trial we have developed a webpage for general cognitive stimulation, which is designed to provide general computer-based cognitive stimulation.

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
CABPad Working Memory Test
Aikaikkuna: After the end of the intervention (8 weeks after baseline)

Test of working memory. The higher score the better (theoretically infinite score)

After the end of the intervention (8 weeks after baseline)

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
CABPad Working Memory Test - 3 months follow-up
Aikaikkuna: At follow-up visit 3 months after end of intervention

Test of working memory. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after end of intervention
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

At follow-up visit 3 months after the end of the intervention
Trail Making A
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making A
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Test of processing speed and visual attention. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Trail Making B
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Trail Making B
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Test of divided attention, mental flexibility. The lower score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
SDMT
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
SDMT
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Symbol Digit Modalities Test: Test of mental speed. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Phonological verbal fluency test
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Phonological verbal fluency test
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Test of verbal phonological fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Categorical verbal fluency test
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

Directly after the intervention, eight weeks after inclusion
Categorical verbal fluency test
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Test of verbal categorical fluency. The higher score the better (theoretically infinite score)

At follow-up visit 3 months after the end of the intervention
Fear questionnaire
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

Directly after the intervention, eight weeks after inclusion
Fear questionnaire
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Questionnaire with 24 items concerning fear on a scale from 0 to 8 where 8 indicates a higher degree of avoidance due to fear

At follow-up visit 3 months after the end of the intervention
mrs: Modified Rankin Scale
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead): Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
mrs: Modified Rankin Scale
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Questionnaire concerning disability on a scale from 0 (no symptoms) to 6 (dead). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
IQCODE (Informant Questionnaire on Cognitive Decline in the Elderly)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Cognitive decline in the elderly, reported by partner. A scale of 16 items from 1 (much better) to 5 (much worse). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
EuroQol-5 domain (EQ-5D-5L)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability . Higher score indicates more severe disability. Completed by patient and partner

Directly after the intervention, eight weeks after inclusion
EuroQol-5 domain (EQ-5D-5L)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Quality of life scale with 5 domains, each rated from 1-5 indicating slight to severe disability. Higher score indicates more severe disability. Completed by patient and partner

At follow-up visit 3 months after the end of the intervention
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinson Disease)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PDQ 39 (Parkinsons Disease Questionnaire: Only in patients with Parkinsons Disease)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Quality of Life questionnaire in patients with Parkinson's Disease. A scale with 39 items rated from 1 (never) to 5 (all the time / Can not do at all). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
Compliance
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Monitoring of total time spent training in minutes

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

Directly after the intervention, eight weeks after inclusion
PHQ-9 (Patient health questionnaire 9)
Aikaikkuna: At follow-up visit 3 months after the end of the intervention

Questionnaire about health of patient with 9 items rated on a 4 point scale from 0 (not at all) to 3 (almost every day). Higher score indicates more severe disability.

At follow-up visit 3 months after the end of the intervention
2) visual analogue scale (1-10)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

After last session: how much they liked doing the training and if they would recommend the intervention to somebody else in their situation. Higher score indicates they liked the training more.

Directly after the intervention, eight weeks after inclusion
Minimum Data Set-Home Care- Instrumental Activities of Daily Living (MDS-HC-IADL)
Aikaikkuna: Directly after the intervention, eight weeks after inclusion

Questionnaire concerning activities of daily living. 0-3 points on an 8-item scale, the fewer points the better.

Directly after the intervention, eight weeks after inclusion

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Maanantai 1. kesäkuuta 2020

Ensisijainen valmistuminen (Arvioitu)

Torstai 5. marraskuuta 2026

Opintojen valmistuminen (Arvioitu)

Perjantai 5. helmikuuta 2027

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Perjantai 3. tammikuuta 2020

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Maanantai 13. tammikuuta 2020

Ensimmäinen Lähetetty (Todellinen)

Tiistai 14. tammikuuta 2020

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Perjantai 2. lokakuuta 2026

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Tiistai 29. syyskuuta 2026

Viimeksi vahvistettu

Tiistai 1. syyskuuta 2026

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

PÄÄTTÄMÄTÖN

IPD-suunnitelman kuvaus

This is currently undecided

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa